Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,otherAssets,totalCurrentLiabilities,totalCurrentAssets,longTermInvestments,netReceivables,cash,changeToLiabilities,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,currency,exchange,marketCap,gmtOffSetMilliseconds,esgPopulated,tradeable,marketState,priceHint,regularMarketChangePercent,regularMarketDayRange,market,exchangeDataDelayedBy,shortName,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Apr 29, 2021) 4","Short Ratio (Apr 29, 2021) 4","Short % of Float (Apr 29, 2021) 4","Short % of Shares Outstanding (Apr 29, 2021) 4","Shares Short (prior month Mar 30, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry,address2
t0,HQH,1054695596.0,44654000,,,96586806,,96586806,2842622,1955980,-886643,-886643,,,,,,0,1955980,2842622,0,97473449,,96586806,96586806,814739571.0,1123538.0,1054695596.0,26316.0,1055819134.0,438717.0,2463000.0,239517308.0,31402.0,52178983.0,1092136.0,6835256.0,996804895.0,4321829.0,,0,5743120.0,en-US,US,EQUITY,True,Delayed Quote,26.62,1630526402,-0.12999916,26.75,26.84,26.62,116541,USD,NYQ,1188689536,-14400000,False,False,PRE,2,-0.4859782,26.62 - 26.84,us_market,0,Tekla Healthcare Investors,26.75,0.0,0.0,8,8,finmb_353071,NYSE,Tekla Healthcare Investors,USD,125771,183171,7.1900005,0.37004635,19.43 - 28.05,-1.4299984,-0.050980337,19.43,28.05,1546214400,1.78,4.8417606,0.06654205,5.498,24.04,26.393715,0.22628593,0.008573478,25.10174,1.518261,0.06048429,1.1073211,15,America/New_York,EDT,1.0,,,28.05,19.43,26.39,25.1,125.77k,183.17k,44.65M,,,0.00%,21.84%,52.77k,0.36,,0.12%,157.98k,2,8.36%,1.78,6.65%,8.91,32.66%,"Dec 30, 2018","May 26, 2021",,,"Sep 29, 2020","Sep 29, 2020","2,700.10%",-22.07%,-0.13%,25.05%,8.93M,0.20,0.50%,8.93M,,241.2M,5.50,,,,,,6.26,24.04,,,Value,02110,Financial Services,"Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.",Boston,617-772-8500,MA,1388448000,United States,http://www.teklacap.com/hqh.html,86400,100 Federal Street,617-772-8577,Asset Management,19th Floor
t-1,HQH,1054695596.0,44654000,,,96586806,,96586806,2842622,1955980,-886643,-886643,,,,,,0,1955980,2842622,0,97473449,,96586806,96586806,814739571.0,1123538.0,1054695596.0,26316.0,1055819134.0,438717.0,2463000.0,239517308.0,31402.0,52178983.0,1092136.0,6835256.0,996804895.0,4321829.0,,0,5743120.0,en-US,US,EQUITY,True,Delayed Quote,26.62,1630526402,-0.12999916,26.75,26.84,26.62,116541,USD,NYQ,1188689536,-14400000,False,False,PRE,2,-0.4859782,26.62 - 26.84,us_market,0,Tekla Healthcare Investors,26.75,0.0,0.0,8,8,finmb_353071,NYSE,Tekla Healthcare Investors,USD,125771,183171,7.1900005,0.37004635,19.43 - 28.05,-1.4299984,-0.050980337,19.43,28.05,1546214400,1.78,4.8417606,0.06654205,5.498,24.04,26.393715,0.22628593,0.008573478,25.10174,1.518261,0.06048429,1.1073211,15,America/New_York,EDT,1.0,,,28.05,19.43,26.39,25.1,125.77k,183.17k,44.65M,,,0.00%,21.84%,52.77k,0.36,,0.12%,157.98k,2,8.36%,1.78,6.65%,8.91,32.66%,"Dec 30, 2018","May 26, 2021",,,"Sep 29, 2020","Sep 29, 2020","2,700.10%",-22.07%,-0.13%,25.05%,8.93M,0.20,0.50%,8.93M,,241.2M,5.50,,,,,,6.26,24.04,,,Value,02110,Financial Services,"Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.",Boston,617-772-8500,MA,1388448000,United States,http://www.teklacap.com/hqh.html,86400,100 Federal Street,617-772-8577,Asset Management,19th Floor
t-2,HQH,883993417.0,44654000,,,24015446,,24015446,2609821,2510606,-99215,-99215,,,,,,0,2510606,2609821,0,24114661,,24015446,24015446,,1053414.0,883993417.0,,885046831.0,798704435.0,24987000.0,85288982.0,,35790971.0,1053414.0,36080608.0,813175252.0,11033663.0,840.0,0,35027194.0,en-US,US,EQUITY,True,Delayed Quote,26.62,1630526402,-0.12999916,26.75,26.84,26.62,116541,USD,NYQ,1188689536,-14400000,False,False,PRE,2,-0.4859782,26.62 - 26.84,us_market,0,Tekla Healthcare Investors,26.75,0.0,0.0,8,8,finmb_353071,NYSE,Tekla Healthcare Investors,USD,125771,183171,7.1900005,0.37004635,19.43 - 28.05,-1.4299984,-0.050980337,19.43,28.05,1546214400,1.78,4.8417606,0.06654205,5.498,24.04,26.393715,0.22628593,0.008573478,25.10174,1.518261,0.06048429,1.1073211,15,America/New_York,EDT,1.0,,,28.05,19.43,26.39,25.1,125.77k,183.17k,44.65M,,,0.00%,21.84%,52.77k,0.36,,0.12%,157.98k,2,8.36%,1.78,6.65%,8.91,32.66%,"Dec 30, 2018","May 26, 2021",,,"Sep 29, 2020","Sep 29, 2020","2,700.10%",-22.07%,-0.13%,25.05%,8.93M,0.20,0.50%,8.93M,,241.2M,5.50,,,,,,6.26,24.04,,,Value,02110,Financial Services,"Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.",Boston,617-772-8500,MA,1388448000,United States,http://www.teklacap.com/hqh.html,86400,100 Federal Street,617-772-8577,Asset Management,19th Floor
t-3,HQH,883993417.0,44654000,,,24015446,,24015446,2609821,2510606,-99215,-99215,,,,,,0,2510606,2609821,0,24114661,,24015446,24015446,,1053414.0,883993417.0,,885046831.0,798704435.0,24987000.0,85288982.0,,35790971.0,1053414.0,36080608.0,813175252.0,11033663.0,840.0,0,35027194.0,en-US,US,EQUITY,True,Delayed Quote,26.62,1630526402,-0.12999916,26.75,26.84,26.62,116541,USD,NYQ,1188689536,-14400000,False,False,PRE,2,-0.4859782,26.62 - 26.84,us_market,0,Tekla Healthcare Investors,26.75,0.0,0.0,8,8,finmb_353071,NYSE,Tekla Healthcare Investors,USD,125771,183171,7.1900005,0.37004635,19.43 - 28.05,-1.4299984,-0.050980337,19.43,28.05,1546214400,1.78,4.8417606,0.06654205,5.498,24.04,26.393715,0.22628593,0.008573478,25.10174,1.518261,0.06048429,1.1073211,15,America/New_York,EDT,1.0,,,28.05,19.43,26.39,25.1,125.77k,183.17k,44.65M,,,0.00%,21.84%,52.77k,0.36,,0.12%,157.98k,2,8.36%,1.78,6.65%,8.91,32.66%,"Dec 30, 2018","May 26, 2021",,,"Sep 29, 2020","Sep 29, 2020","2,700.10%",-22.07%,-0.13%,25.05%,8.93M,0.20,0.50%,8.93M,,241.2M,5.50,,,,,,6.26,24.04,,,Value,02110,Financial Services,"Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.",Boston,617-772-8500,MA,1388448000,United States,http://www.teklacap.com/hqh.html,86400,100 Federal Street,617-772-8577,Asset Management,19th Floor
